DNMT1 and plasma cell myeloma: The synergistic effect of RRx-001 and P5091 was demonstrated in studies by Das et al. where multiple myeloma (MM) cells have been demonstrated to benefit from increased levels of DNA (cytosine-5)-methyltransferase 1 (DNMT1), the primary enzyme that promotes DNA methylation.